BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32168228)

  • 1. Inconsistent Mandated Access to Fertility Preservation: A Review of Relevant State Legislation.
    Sax MR; Pavlovic Z; DeCherney AH
    Obstet Gynecol; 2020 Apr; 135(4):848-851. PubMed ID: 32168228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility Preservation Legislation in the United States: Potential Implications for Transgender Individuals.
    Kyweluk MA; Reinecke J; Chen D
    LGBT Health; 2019 Oct; 6(7):331-334. PubMed ID: 31436497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-a human right worthy of mandated insurance coverage: the evolution, limitations, and future of access to care.
    Kawwass JF; Penzias AS; Adashi EY
    Fertil Steril; 2021 Jan; 115(1):29-42. PubMed ID: 33342534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    Walter JR; Xu S; Woodruff TK
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Health Insurance Benefit Mandates for Fertility Preservation Among 11 US States.
    Flores Ortega RE; Yoeun SW; Mesina O; Kaiser BN; McMenamin SB; Su HI
    JAMA Health Forum; 2021 Dec; 2(12):e214309. PubMed ID: 36218913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mandating Coverage for Fertility Preservation - A Step in the Right Direction.
    Cardozo ER; Huber WJ; Stuckey AR; Alvero RJ
    N Engl J Med; 2017 Oct; 377(17):1607-1609. PubMed ID: 29069561
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of state health insurance benefit mandates for cancer-related fertility preservation: following policy through a complex system.
    Su HI; Kaiser BN; Crable EL; Ortega RF; Yoeun SW; Economou MA; Fernandez E; Romero SAD; Aarons GA; McMenamin SB
    Implement Sci; 2024 Feb; 19(1):14. PubMed ID: 38365808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment.
    Peipert BJ; Montoya MN; Bedrick BS; Seifer DB; Jain T
    Reprod Biol Endocrinol; 2022 Aug; 20(1):111. PubMed ID: 35927756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues.
    Oliveira BL; Ataman LM; Rodrigues JK; Birchal TS; Reis FM
    Reprod Biomed Online; 2021 Sep; 43(3):571-576. PubMed ID: 34332903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Reported Fertility Preservation Counseling Before Chemotherapy Using the Quality Oncology Practice Initiative Survey.
    Patel P; Kohn TP; Cohen J; Shiff B; Kohn J; Ramasamy R
    JAMA Netw Open; 2020 Jul; 3(7):e2010806. PubMed ID: 32678451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility Preservation and Financial Hardship among Adolescent and Young Adult Women with Cancer.
    Meernik C; Mersereau JE; Baggett CD; Engel SM; Moy LM; Cannizzaro NT; Peavey M; Kushi LH; Chao CR; Nichols HB
    Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1043-1051. PubMed ID: 35506248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options for Fertility Preservation in Children.
    Javed A; Khan Z; Pittock ST; Jensen JR
    Pediatr Endocrinol Rev; 2018 Mar; 15(3):223-233. PubMed ID: 29493127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of the Law in Helping or Hindering Fertility Preservation for Children with Cancer Facing Gonadotoxic Therapies.
    Allan S; Gook D; Jayasinghe Y
    J Law Med; 2018 Dec; 26(2):322-333. PubMed ID: 30574721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Fertility Preservation for Young Women With Cancer.
    Smith KL; Gracia C; Sokalska A; Moore H
    Am Soc Clin Oncol Educ Book; 2018 May; 38():27-37. PubMed ID: 30231357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
    Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
    Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male Fertility Preservation.
    Abram McBride J; Lipshultz LI
    Curr Urol Rep; 2018 May; 19(7):49. PubMed ID: 29774444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologists' and pediatric oncologists' perspectives and challenges for fertility preservation.
    Lampic C; Wettergren L
    Acta Obstet Gynecol Scand; 2019 May; 98(5):598-603. PubMed ID: 30714120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.
    Baysal Ö; Bastings L; Beerendonk CC; Postma SA; IntHout J; Verhaak CM; Braat DD; Nelen WL
    Hum Reprod; 2015 Jul; 30(7):1625-34. PubMed ID: 26034191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical, ethical, and legal considerations in fertility preservation.
    Shah DK; Goldman E; Fisseha S
    Int J Gynaecol Obstet; 2011 Oct; 115(1):11-5. PubMed ID: 21767834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-Site Fertility Preservation Services for Adolescents and Young Adults in a Comprehensive Cancer Center.
    Peavey M; Arian S; Gibbons W; Lu K; Gershenson D; Woodard T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):229-234. PubMed ID: 27845854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.